Fractional Exhaled Nitric Oxide (FeNO) Result Prediction Factors in Children With Allergic Diseases
FeNO Result Prediction Factors in Children With Allergic Diseases
1 other identifier
observational
800
1 country
1
Brief Summary
In about 800 children with allergic diseases (asthma, allergic rhinitis, atopic dermatitis) the investigators will retrospectively and cross-sectionally analyze the influence/correlation of diagnosis, treatment methods, allergy status (skin prick test results), lung function tests results on/with the concentration of nitric oxide in exhaled breath.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jan 2009
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
December 30, 2008
CompletedFirst Posted
Study publicly available on registry
December 31, 2008
CompletedStudy Start
First participant enrolled
January 1, 2009
CompletedPrimary Completion
Last participant's last visit for primary outcome
January 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
January 1, 2010
CompletedFebruary 10, 2010
February 1, 2010
1 year
December 30, 2008
February 9, 2010
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Concentration of nitric oxide in exhaled breath.
1-4 months
Study Arms (1)
Schoolchildren with asthma.
Schoolchildren with asthma.
Interventions
Measurement of the concentration of FeNO , measurement of spirometry, plethysmography, exercise challenge test (ECT -spirometric), bronchial obstruction reversibility pharmacological test
Eligibility Criteria
Children with asthma (allergic), and/or allergic rhinitis and/or atopic dermatitis
You may qualify if:
- Children with asthma (allergic), and/or allergic rhinitis and/or atopic dermatitis
You may not qualify if:
- Other chronic diseases
- Asthma exacerbation
- Pregnancy
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Department of Pediatrics and Allergy, N. Copernicus Hospital
Lodz, 93-513, Poland
Related Publications (1)
Grzelewski T, Majak P, Jerzynska J, Stelmach W, Stelmach R, Janas A, Grzelewska A, Witkowski K, Makandjou-Ola E, Stelmach I. The interpretation of exhaled nitric oxide values in children with asthma depends on the degree of bronchoconstriction and the levels of asthma severity. Respir Care. 2014 Sep;59(9):1404-11. doi: 10.4187/respcare.02889. Epub 2013 Dec 31.
PMID: 24381190DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Iwona Stelmach, MD PhD Prof
Department of Pediatrics and Allergy, N. Copernicus Hospital, Lodz, Poland
- PRINCIPAL INVESTIGATOR
Tomasz Grzelewski, MD, PhD
Department of Pediatrics and Allergy, N. Copernicus Hospital, Lodz, Poland
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
December 30, 2008
First Posted
December 31, 2008
Study Start
January 1, 2009
Primary Completion
January 1, 2010
Study Completion
January 1, 2010
Last Updated
February 10, 2010
Record last verified: 2010-02